Real world data to identify target population for new CAR‐T therapies-Reference-Cited by-同舟云学术

Real world data to identify target population for new CAR‐T therapies

Published:2020-11-11 Issue:1 Volume:30 Page:78-85
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Belleudi Valeria¹^ORCID,Trotta Francesco²,Fortinguerra Filomena²,Poggi Francesca R.¹,Olimpieri Odoardo²,Santelli Enrica¹,Cozzi Ilaria¹,Michelozzi Paola¹,Addis Antonio¹^ORCID

Affiliation:

1. Department of Epidemiology Lazio Regional Health Service Rome Italy

2. Italian Medicines Agency (AIFA) Rome Italy

Funder

Regione Lazio

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5165

Reference19 articles.

1. The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). Guide on Methodological Standards in Pharmacoepidemiology (Revision 5). EMA/95098/2010.2010;http://www.encepp.eu/standards_and_guidances. Accessed January 9 2020.

2. Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe

3. The FDA's Real‐World Evidence website. Real‐world data (RWD) and real‐world evidence (RWE) are playing an increasing role in health care decisions.2020;https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence. Accessed January 9 2020.

4. Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world data analysis on effectiveness of integrative therapies: A practical guide to study design and data analysis using healthcare databases;Integrative Medicine Research;2023-12

2. Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries;Frontiers in Medicine;2023-05-30

3. Barriers to patient access of CAR T cell therapies in Austria;memo - Magazine of European Medical Oncology;2023-01-31

4. CAR T-Cell Therapies in Italy: Patient Access Barriers and Recommendations for Health System Solutions;Frontiers in Pharmacology;2022-06-23